HOUSE OF REPRESENTATIVESSENATEHealth & Human Services, Dept of (HHS)Commerce, Dept of (DOC)Executive Office of the President (EOP)U.S. Trade Representative (USTR)
Specific issues
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Pharmacy · 2026 Q1
General issues related to skin substitutes.
Health Issues · 2026 Q1
General issues related to rare disease treatment.
Health Issues · 2026 Q1
General issues related to rare disease treatment development.
Taxation/Internal Revenue Code · 2026 Q1
General issues related to tariffs.
Trade (domestic/foreign) · 2026 Q1
General healthcare issues related to biosimilar industries.